Suraksha Diagnostic Ltd. IPO – A Detailed Analysis - English

India’s diagnostics sector shows immense potential, which is expected to grow at a CAGR of 14%, valuing the industry to ~US$25 Billion by 2028, driven by rising health awareness, government healthcare initiatives, and increasing demand for preventive diagnostics. Suraksha Diagnostics, with its expanding network offering pathology and radiology services, aims to capture a share of this expanding market. But is this IPO your gateway to healthy portfolio growth? Let’s analyze its business, financials, and valuations to decide if it’s a good fit, for your portfolio?